U.A.E. Endorses Sinopharm Coronavirus Vaccine For General Use, Says Data Show 86% Efficacy

New York Times: Chinese vaccine is 86 percent effective, says U.A.E., where trials were held.
“The United Arab Emirates said on Wednesday that it approved a Chinese coronavirus vaccine that is being tested in the country after preliminary data showed that it was 86 percent effective. The U.A.E.’s Ministry of Health and Prevention said it reviewed an interim analysis by Sinopharm, a Chinese state-owned vaccine maker, of data from late-stage clinical trials that showed its vaccine was 86 percent effective in preventing infection from Covid-19. Sinopharm’s analysis showed the vaccine was 100 percent effective in preventing moderate and severe cases of the disease and that there were no serious safety concerns, the government said. It did not say if it conducted an independent analysis of the raw data…” (Wee, 12/9).

Additional coverage of U.A.E.’s analysis of the Sinopharm vaccine data is available from Bloomberg, CNBC, NPR, and Washington Post.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.